Overview

The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus

Status:
Not yet recruiting

Trial end date:
2021-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the efficacy and safety of DWP16001 compared to active drug in the treatment of type 2 diabetes mellitus.

Phase:

Phase 3

Details

Lead Sponsor:

Daewoong Pharmaceutical Co. LTD.